Aurinia Pharmaceuticals Inc. buy klostergang
Start price
06.04.17
/
50%
€6.18
Target price
09.10.17
€9.00
Performance (%)
-9.83%
End price
09.10.17
€5.57
Summary
This prediction ended on 09.10.17 with a price of €5.57. With a performance of -9.83%, the BUY prediction by klostergang finished with a loss. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 11.082% | 11.082% | 43.474% | 64.278% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % | 64,06 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % | 86,92 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % | 77,87 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % | 68,19 % |
Comments by klostergang for this prediction
In the thread Aurinia Pharmaceuticals Inc. diskutieren
Aurinia Pharmaceuticals: Highlighting an Important Clinical and Regulatory Change
klostergang stimmt am 06.04.2017 der fundamentalen Bewertung mit dem Ergebnis überbewertet nicht zu.
(Laufzeit überschritten)